| OA (n = 23) | RA (n = 30) |
---|---|---|
Male/female, n | 2/21 | 6/24 |
Age, mean ± SD (range, years) | 76.6 ± 5.8 (64–84) | 69.4 ± 8.1 (55–83) |
Disease duration, mean ± SD (years) | 10.7 ± 5.1 | 16.3 ± 9.1 |
CRP, mean ± SD (mg/dl) | 0.16 ± 0.30 | 1.43 ± 1.21 |
DAS28-CRP, mean ± SD | – | 3.74 ± 0.84 |
Medications | Â | Â |
Prednisolone, n (%) | NA | 17 (56.7) |
Methotrexate, n (%) | NA | 15 (50.0) |
Sulfasalazine, n (%) | NA | 7 (23.3) |
Bucillamine, n (%) | NA | 6 (20.0) |
Cyclosporine, n (%) | NA | 3 (10.0) |
Actarit, n (%) | NA | 1 (3.3) |
TNF-α blockade, n (%) | NA | 4 (13.3) |